tiprankstipranks
Trending News
More News >
iAnthus Capital Holdings Inc (TSE:IAN)
:IAN
Advertisement

iAnthus Capital Holdings (IAN) AI Stock Analysis

Compare
93 Followers

Top Page

TSE:IAN

iAnthus Capital Holdings

(OTC:IAN)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 4o)
Rating:43Neutral
Price Target:
C$0.00
▼(-100.00% Downside)
The overall stock score is primarily impacted by the company's financial challenges, including high leverage and weak cash flow generation. Technical analysis indicates a lack of momentum, and valuation metrics suggest the stock is fairly valued but not particularly attractive without a dividend yield. The absence of earnings call data and corporate events means these factors do not influence the score.

iAnthus Capital Holdings (IAN) vs. iShares MSCI Canada ETF (EWC)

iAnthus Capital Holdings Business Overview & Revenue Model

Company DescriptioniAnthus Capital Holdings, Inc. is a leading cannabis company based in the United States, focusing on the cultivation, processing, and sale of cannabis and cannabis-related products. The company operates in several regulated markets, primarily through its subsidiaries, and is involved in both retail and wholesale distribution of cannabis products. iAnthus aims to provide high-quality cannabis experiences to its customers while adhering to strict regulatory standards across its operating states.
How the Company Makes MoneyiAnthus Capital Holdings generates revenue through multiple streams, primarily focusing on the sale of cannabis products in retail dispensaries and wholesale distribution to other retailers. The company operates its own dispensaries, where it sells various cannabis products, including dried flower, edibles, and concentrates, directly to consumers. Additionally, iAnthus earns revenue from its cultivation and processing facilities, which produce cannabis products for both its retail outlets and for wholesale distribution. Significant partnerships with local businesses and other cannabis brands enhance its distribution capabilities and market presence. The company's focus on expanding its footprint in the cannabis industry and optimizing its operations contributes to its overall revenue growth.

iAnthus Capital Holdings Financial Statement Overview

Summary
iAnthus Capital Holdings is facing significant financial challenges. While there are signs of improvement in profitability, the company struggles with declining revenue, high leverage, and weak cash flow generation. The negative equity position and high debt levels pose substantial risks, requiring strategic financial management to stabilize and improve the company's financial health.
Income Statement
45
Neutral
The income statement shows a mixed performance. The company has managed to improve its net profit margin to 6.98% in TTM from negative margins in previous years, indicating a turnaround in profitability. However, revenue has declined by 4.76% in the TTM period, and EBIT remains negative, reflecting ongoing operational challenges. The gross profit margin is relatively stable at 46.79%, suggesting some pricing power or cost control.
Balance Sheet
30
Negative
The balance sheet is concerning, with a negative stockholders' equity and a high debt-to-equity ratio of -3.56 in TTM, indicating financial instability and high leverage. The negative return on equity further highlights the company's inability to generate returns for shareholders. The equity ratio is negative, reflecting a precarious financial position.
Cash Flow
40
Negative
Cash flow analysis reveals significant volatility. The free cash flow has drastically decreased by 89.18% in TTM, and the operating cash flow to net income ratio is low at 0.18, indicating weak cash generation relative to net income. However, the company has managed to maintain positive operating cash flow, which is a positive sign amidst the challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue156.31M167.57M159.24M163.21M203.02M151.67M
Gross Profit72.25M75.11M63.17M74.43M111.28M86.68M
EBITDA29.02M21.22M-13.30M-369.80M7.89M-241.27M
Net Income2.58M-7.64M-76.62M-449.39M-76.25M-310.03M
Balance Sheet
Total Assets268.68M271.04M277.41M303.47M346.74M357.97M
Cash, Cash Equivalents and Short-Term Investments23.46M18.54M13.10M14.34M13.24M11.02M
Total Debt219.32M210.46M201.00M183.94M228.54M206.29M
Total Liabilities346.59M336.58M339.07M292.48M369.14M307.13M
Stockholders Equity-77.92M-65.54M-61.67M10.99M-22.40M50.84M
Cash Flow
Free Cash Flow480.00K7.03M-3.06M-26.55M-4.25M-27.33M
Operating Cash Flow12.93M12.54M3.02M-19.50M16.15M-13.07M
Investing Cash Flow3.58M-6.28M-3.63M-4.74M-21.32M-11.49M
Financing Cash Flow-9.52M-339.00K-618.00K22.06M10.24M1.26M

iAnthus Capital Holdings Risk Analysis

iAnthus Capital Holdings disclosed 65 risk factors in its most recent earnings report. iAnthus Capital Holdings reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

iAnthus Capital Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
74.97M4.8113.88%-0.53%
65
Neutral
28.26M28.726.03%34.71%
45
Neutral
29.45M-3.35-21.74%17.74%37.61%
43
Neutral
$101.08M16.6761.65%-4.39%
42
Neutral
29.45M-18.66-50.26%2.00%80.83%
40
Underperform
18.10M-0.04-94.67%0.63%-31.86%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:IAN
iAnthus Capital Holdings
0.01
0.00
0.00%
AYRWF
Ayr Wellness
0.02
-1.68
-98.82%
MEDIF
MediPharm Labs
0.05
0.00
0.00%
DBCCF
Decibel Cannabis Company
0.09
0.05
125.00%
MILFF
1CM Inc
0.31
0.13
72.22%
AVCNF
Avicanna
0.17
-0.07
-29.17%

iAnthus Capital Holdings Corporate Events

Business Operations and StrategyFinancial Disclosures
iAnthus Capital Holdings Shows Improved Margins Amid Revenue Decline in Q1 2025
Neutral
May 13, 2025

iAnthus Capital Holdings reported a revenue of $38.1 million for Q1 2025, marking a decline from both the previous quarter and the same period last year. Despite the revenue drop, the company saw an improvement in gross margin and a net income of $5.1 million, indicating a positive shift from a net loss in the previous year, which could signal a strengthening position in the cannabis market.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 20, 2025